| ADOCIA SAS EO -,10 |
| Frankreich |
| Gesundheit |
| FR0011184241 / A1JTC2 |
| A89 (Frankfurt) |
| FRA:A89, ETR:A89, A89:GR |
| - |
| https://www.adocia.com/ |
|
Adocia SA is a French clinical-stage biotechnology company headquartered in Lyon, specializing in the discovery and development of innovative therapeutic solutions for chronic metabolic diseases, particularly diabetes and obesity. Founded in 2005 by ..
>Volltext.. |
| 77.81 Mio. EUR |
| 69.45 Mio. EUR |
| 1.52 Mio. EUR |
| -18.11 Mio. EUR |
| -17.05 Mio. EUR |
| -0.95 EUR |
| 9.15 Mio. EUR |
| 17.73 Mio. EUR |
| -6.71 Mio. EUR |
| 0.86 |
| -84.17% |
| -78% |
| - |
| - |
| - |
| - |
| ADOCIA |
| 17.07.26 |
|
||||
|